From today at the Global Healthcare Conference in New York. A confident Axovant CEO discussing his pipeline and multiple "silence and replace" targets (2:17). This is a reference to the 5 joint Axovant - Benitec programs that are being developed and will be announced in "coming months"
Benitec (ddrnai technology) which languished for years on the ASX will finally be demonstrated in the largest financial markets in the world by world-class scientists and investors.
